UniProt ID | DPP3_HUMAN | |
---|---|---|
UniProt AC | Q9NY33 | |
Protein Name | Dipeptidyl peptidase 3 | |
Gene Name | DPP3 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 737 | |
Subcellular Localization | Cytoplasm, cytosol . | |
Protein Description | Cleaves and degrades bioactive peptides, including angiotensin, Leu-enkephalin and Met-enkephalin. [PubMed: 3233187] | |
Protein Sequence | MADTQYILPNDIGVSSLDCREAFRLLSPTERLYAYHLSRAAWYGGLAVLLQTSPEAPYIYALLSRLFRAQDPDQLRQHALAEGLTEEEYQAFLVYAAGVYSNMGNYKSFGDTKFVPNLPKEKLERVILGSEAAQQHPEEVRGLWQTCGELMFSLEPRLRHLGLGKEGITTYFSGNCTMEDAKLAQDFLDSQNLSAYNTRLFKEVDGEGKPYYEVRLASVLGSEPSLDSEVTSKLKSYEFRGSPFQVTRGDYAPILQKVVEQLEKAKAYAANSHQGQMLAQYIESFTQGSIEAHKRGSRFWIQDKGPIVESYIGFIESYRDPFGSRGEFEGFVAVVNKAMSAKFERLVASAEQLLKELPWPPTFEKDKFLTPDFTSLDVLTFAGSGIPAGINIPNYDDLRQTEGFKNVSLGNVLAVAYATQREKLTFLEEDDKDLYILWKGPSFDVQVGLHELLGHGSGKLFVQDEKGAFNFDQETVINPETGEQIQSWYRSGETWDSKFSTIASSYEECRAESVGLYLCLHPQVLEIFGFEGADAEDVIYVNWLNMVRAGLLALEFYTPEAFNWRQAHMQARFVILRVLLEAGEGLVTITPTTGSDGRPDARVRLDRSKIRSVGKPALERFLRRLQVLKSTGDVAGGRALYEGYATVTDAPPECFLTLRDTVLLRKESRKLIVQPNTRLEGSDVQLLEYEASAAGLIRSFSERFPEDGPELEEILTQLATADARFWKGPSEAPSGQA | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MADTQYILP ------CCCCCEECC | 28.67 | 22223895 | |
4 | Phosphorylation | ----MADTQYILPND ----CCCCCEECCCC | 17.46 | 24043423 | |
6 | Phosphorylation | --MADTQYILPNDIG --CCCCCEECCCCCC | 13.40 | 24043423 | |
15 | Phosphorylation | LPNDIGVSSLDCREA CCCCCCCCCCCHHHH | 21.70 | 24043423 | |
16 | Phosphorylation | PNDIGVSSLDCREAF CCCCCCCCCCHHHHH | 26.31 | 24043423 | |
27 | Phosphorylation | REAFRLLSPTERLYA HHHHHHCCHHHHHHH | 34.07 | 22210691 | |
29 | Phosphorylation | AFRLLSPTERLYAYH HHHHCCHHHHHHHHH | 30.29 | - | |
35 | Phosphorylation | PTERLYAYHLSRAAW HHHHHHHHHHHHHHH | 6.96 | 22210691 | |
113 | Ubiquitination | YKSFGDTKFVPNLPK CCCCCCCCCCCCCCH | 49.45 | 21906983 | |
113 (in isoform 1) | Ubiquitination | - | 49.45 | 21906983 | |
113 (in isoform 2) | Ubiquitination | - | 49.45 | 21906983 | |
130 | Phosphorylation | LERVILGSEAAQQHP HHHHHHCHHHHHHCH | 22.18 | 23911959 | |
153 | O-linked_Glycosylation | TCGELMFSLEPRLRH HHHHHHHCCHHHHHH | 20.18 | 30379171 | |
165 | Ubiquitination | LRHLGLGKEGITTYF HHHCCCCCCCCEEEE | 58.78 | - | |
169 (in isoform 2) | Phosphorylation | - | 26.71 | 23663014 | |
170 (in isoform 2) | Phosphorylation | - | 22.20 | 23663014 | |
171 | Phosphorylation | GKEGITTYFSGNCTM CCCCCEEEEECCCCH | 6.26 | 23663014 | |
171 (in isoform 2) | Phosphorylation | - | 6.26 | 23663014 | |
173 (in isoform 2) | Phosphorylation | - | 20.77 | 23663014 | |
177 (in isoform 2) | Phosphorylation | - | 27.82 | 23663014 | |
178 | Sulfoxidation | YFSGNCTMEDAKLAQ EEECCCCHHHHHHHH | 4.84 | 30846556 | |
202 | Acetylation | AYNTRLFKEVDGEGK HHHHEEEEEECCCCC | 62.51 | 25953088 | |
202 | Ubiquitination | AYNTRLFKEVDGEGK HHHHEEEEEECCCCC | 62.51 | 21906983 | |
202 (in isoform 1) | Ubiquitination | - | 62.51 | 21906983 | |
209 (in isoform 1) | Ubiquitination | - | 26.08 | 21906983 | |
209 (in isoform 2) | Ubiquitination | - | 26.08 | 21906983 | |
209 | Ubiquitination | KEVDGEGKPYYEVRL EEECCCCCEEEEEEH | 26.08 | 21906983 | |
211 | Phosphorylation | VDGEGKPYYEVRLAS ECCCCCEEEEEEHHH | 18.75 | 28796482 | |
212 | Phosphorylation | DGEGKPYYEVRLASV CCCCCEEEEEEHHHH | 19.24 | 28796482 | |
218 | Phosphorylation | YYEVRLASVLGSEPS EEEEEHHHHHCCCCC | 23.59 | - | |
233 (in isoform 1) | Ubiquitination | - | 51.04 | 21906983 | |
233 | Acetylation | LDSEVTSKLKSYEFR CCHHHHHHCCCCEEC | 51.04 | 25953088 | |
233 | Ubiquitination | LDSEVTSKLKSYEFR CCHHHHHHCCCCEEC | 51.04 | 21906983 | |
235 | Ubiquitination | SEVTSKLKSYEFRGS HHHHHHCCCCEECCC | 55.52 | 21906983 | |
235 (in isoform 1) | Ubiquitination | - | 55.52 | 21906983 | |
236 | Phosphorylation | EVTSKLKSYEFRGSP HHHHHCCCCEECCCC | 40.09 | 24719451 | |
257 (in isoform 1) | Ubiquitination | - | 44.81 | 21906983 | |
257 | Ubiquitination | DYAPILQKVVEQLEK CHHHHHHHHHHHHHH | 44.81 | 21906983 | |
264 | 2-Hydroxyisobutyrylation | KVVEQLEKAKAYAAN HHHHHHHHHHHHHCC | 64.87 | - | |
264 (in isoform 1) | Ubiquitination | - | 64.87 | 21906983 | |
264 | Ubiquitination | KVVEQLEKAKAYAAN HHHHHHHHHHHHHCC | 64.87 | 21906983 | |
272 | Phosphorylation | AKAYAANSHQGQMLA HHHHHCCCHHHHHHH | 16.68 | 26657352 | |
286 | Phosphorylation | AQYIESFTQGSIEAH HHHHHHHHHCCCCHH | 41.10 | - | |
289 | Phosphorylation | IESFTQGSIEAHKRG HHHHHHCCCCHHHCC | 13.87 | - | |
294 | Ubiquitination | QGSIEAHKRGSRFWI HCCCCHHHCCCCEEE | 66.55 | - | |
294 | Acetylation | QGSIEAHKRGSRFWI HCCCCHHHCCCCEEE | 66.55 | 24431683 | |
297 | Phosphorylation | IEAHKRGSRFWIQDK CCHHHCCCCEEEECC | 28.47 | - | |
307 (in isoform 2) | Ubiquitination | - | 7.97 | 21906983 | |
337 | Ubiquitination | GFVAVVNKAMSAKFE HHHHHHCHHHHHHHH | 33.58 | 21906983 | |
337 (in isoform 1) | Ubiquitination | - | 33.58 | 21906983 | |
342 | Ubiquitination | VNKAMSAKFERLVAS HCHHHHHHHHHHHHC | 40.21 | - | |
355 | Ubiquitination | ASAEQLLKELPWPPT HCHHHHHHHCCCCCC | 66.84 | - | |
405 | Ubiquitination | LRQTEGFKNVSLGNV HHCCCCCCCCCHHHH | 68.26 | - | |
408 | Phosphorylation | TEGFKNVSLGNVLAV CCCCCCCCHHHHHHH | 39.70 | 21712546 | |
423 | Ubiquitination | AYATQREKLTFLEED HHHHHHHHCEEEECC | 55.82 | - | |
425 | Phosphorylation | ATQREKLTFLEEDDK HHHHHHCEEEECCCC | 36.92 | 16097034 | |
459 | Ubiquitination | LLGHGSGKLFVQDEK HHCCCCCEEEEECCC | 40.21 | - | |
466 (in isoform 1) | Ubiquitination | - | 64.92 | 21906983 | |
466 | Ubiquitination | KLFVQDEKGAFNFDQ EEEEECCCCCCCCCC | 64.92 | 21906983 | |
498 | Ubiquitination | SGETWDSKFSTIASS CCCCCCHHHHHHHHC | 40.64 | - | |
615 | Ubiquitination | SKIRSVGKPALERFL HHHHHCCHHHHHHHH | 25.59 | - | |
629 (in isoform 1) | Ubiquitination | - | 47.30 | 21906983 | |
629 | Ubiquitination | LRRLQVLKSTGDVAG HHHHHHHHHCCCCCC | 47.30 | 21906983 | |
630 | Phosphorylation | RRLQVLKSTGDVAGG HHHHHHHHCCCCCCC | 33.20 | 23403867 | |
631 | Phosphorylation | RLQVLKSTGDVAGGR HHHHHHHCCCCCCCC | 35.50 | 23403867 | |
641 | Phosphorylation | VAGGRALYEGYATVT CCCCCEEEEEEEEEC | 13.31 | 23403867 | |
644 | Phosphorylation | GRALYEGYATVTDAP CCEEEEEEEEECCCC | 6.27 | 23403867 | |
646 | Phosphorylation | ALYEGYATVTDAPPE EEEEEEEEECCCCCC | 18.56 | 23403867 | |
648 | Phosphorylation | YEGYATVTDAPPECF EEEEEEECCCCCCCE | 23.30 | 23403867 | |
670 | Ubiquitination | LLRKESRKLIVQPNT EEECCCCCEEECCCC | 52.42 | - | |
677 | Phosphorylation | KLIVQPNTRLEGSDV CEEECCCCCCCCCCC | 43.23 | - | |
682 | Phosphorylation | PNTRLEGSDVQLLEY CCCCCCCCCCEEEEH | 25.82 | 27251275 | |
689 | Phosphorylation | SDVQLLEYEASAAGL CCCEEEEHHHHHHHH | 19.43 | 26074081 | |
692 | Phosphorylation | QLLEYEASAAGLIRS EEEEHHHHHHHHHHH | 13.50 | 26074081 | |
698 | Methylation | ASAAGLIRSFSERFP HHHHHHHHHHHHHCC | 36.37 | - | |
699 | Phosphorylation | SAAGLIRSFSERFPE HHHHHHHHHHHHCCC | 26.57 | 26074081 | |
701 | Phosphorylation | AGLIRSFSERFPEDG HHHHHHHHHHCCCCC | 29.16 | 26074081 | |
716 | Phosphorylation | PELEEILTQLATADA HHHHHHHHHHHHCCC | 27.48 | 26074081 | |
720 | Phosphorylation | EILTQLATADARFWK HHHHHHHHCCCCCCC | 33.39 | 26074081 | |
727 | Ubiquitination | TADARFWKGPSEAPS HCCCCCCCCCCCCCC | 59.23 | 2190698 | |
727 (in isoform 1) | Ubiquitination | - | 59.23 | 21906983 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of DPP3_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of DPP3_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of DPP3_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
A4_HUMAN | APP | physical | 21832049 | |
DLDH_HUMAN | DLD | physical | 22863883 | |
NDRG1_HUMAN | NDRG1 | physical | 22863883 | |
SPSY_HUMAN | SMS | physical | 22863883 | |
TNG2_HUMAN | TANGO2 | physical | 26344197 | |
KEAP1_HUMAN | KEAP1 | physical | 21516116 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Global phosphoproteome analysis on human HepG2 hepatocytes usingreversed-phase diagonal LC."; Gevaert K., Staes A., Van Damme J., De Groot S., Hugelier K.,Demol H., Martens L., Goethals M., Vandekerckhove J.; Proteomics 5:3589-3599(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-425, AND MASSSPECTROMETRY. |